Biomedical device company committed to bringing new freedom and ease of use to people living with diabetes
CellNovo has raised €35M across 1 funding round from 4 investors, most recently a Series B round in Feb 2011. Based in Kings Road Swansea Waterfront, UK; founded 2002; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2011-02-01 | Series B | €35M |
| Advent Venture Partners,Forbion Capital Partners,NBGI Ventures,NESTA Investments |
| View deal → |
